Research Study

AMPLATZER™ LAA Occluder Post Approval Study (PAS)
Principal Investigator 
Jacqueline Saw

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT02964208
Status 
Recruiting
Study Start/End 
Jan 1, 2017 to Jan 1, 2022
Locations 
Vancouver General Hospital
Name/Title 
Naomi Uchida, Research Coordinator
Phone 
604-875-4521
Email Address 
naomi.uchida@ubc.ca
Purpose of Study 

The AMPLATZER LAA Occluder is a transcatheter, self-expanding nitinol device intended for use in preventing thrombus embolization from the LAA. The purpose of this study is to compile real world outcome data on the use of AMPLATZER LAA Occluder in subjects with non-valvular atrial fibrillation (NVAF)

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.